Processing

Please wait...

Settings

Settings

1. WO1996004917 - REMEDY FOR MYOTONIC DYSTROPHY

Publication Number WO/1996/004917
Publication Date 22.02.1996
International Application No. PCT/JP1995/001561
International Filing Date 07.08.1995
Chapter 2 Demand Filed 05.02.1996
IPC
A61K 9/08 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
A61K 9/48 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
A61K 31/56 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A61K 31/565 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
565not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
A61K 31/5685 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
565not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
568substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
5685having an oxo group in position 17, e.g. androsterone
C07J 1/00 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
JSTEROIDS
1Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane
CPC
A61K 31/5685
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
565not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
568substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
5685having an oxo group in position 17, e.g. androsterone
Applicants
  • KANEBO LTD. [JP/JP]; 17-4, Sumida 5-chome Sumida-ku Tokyo 131, JP (AllExceptUS)
  • OHSAWA, Nakaaki [JP/JP]; JP (UsOnly)
  • SUGINO, Masakazu [JP/JP]; JP (UsOnly)
  • ENDO, Tomio [JP/JP]; JP (UsOnly)
Inventors
  • OHSAWA, Nakaaki; JP
  • SUGINO, Masakazu; JP
  • ENDO, Tomio; JP
Agents
  • YASUTOMI, Yasuo ; Recruit Shin Osaka Building 4F 14-22, Nishinakajima 5-chome Yodogawa-ku Osaka-shi Osaka 532, JP
Priority Data
6/20593908.08.1994JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) REMEDY FOR MYOTONIC DYSTROPHY
(FR) REMEDE CONTRE LA MYOTONIE ATROPHIQUE
Abstract
(EN)
A remedy for myotonic dystrophy, containing dehydroepiandrosterone sulfate or a pharmacologically acceptable salt thereof, being efficacious for myotonia, adynamia and amyotrophy, and having a high safety.
(FR)
L'invention se rapporte à un remède contre la myotonie atrophique et contenant un sulfate de déshydroépiandrostérone ou un sel pharmacologiquement acceptable de celui-ci. Ce remède s'avère efficace pour traiter la myotonie, l'adynamie et l'amyotrophie et présente une grande innocuité.
Also published as
Latest bibliographic data on file with the International Bureau